Navigation Links
Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
Date:4/2/2009

rnardo, Jennifer Reyes, New Jersey Plastic Surgery & MedNet Technologies, Inc., Montclair, New Jersey; Bo Chen, Mirko Mirkov, Cynosure, Inc., Westford, Massachusetts
  • "Clinical Evaluation of a Single-Wavelength Fractional Laser and a Novel Multi-Wavelength Fractional Laser in the Treatment of Photodamaged Skin," Laurel Naversen Geraghty, Brian Biesman, New York University School of Medicine, New York, New York, Vanderbilt University Medical Center, Nashville, Tennessee
  • "A Comparison of Three Separate Clinical Studies Evaluating the Safety and Efficacy of Laser-Assisted Lipolysis Using 1064nm, 1320nm and a Combined 1064/1320nm MultiPlex Device," Katrina E. Woodhall, Raminder Saluja, Jane Khoury, Mitchel P. Goldman, La Jolla Spa MD, La Jolla, California

    • About ASLMS

    The American Society for Laser Medicine and Surgery is the world's largest scientific organization dedicated to promoting research, education and high standards of clinical care in the field of medical laser applications. It provides a forum for the exchange of scientific information and participates in communicating the latest developments in laser medicine and surgery to clinicians, research investigators, government and regulatory agencies, and the public. Founded in 1980, the Society has more than 4,000 members.

    About Cynosure, Inc.

    Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions,

    SOURCE Cynosure, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    1

    GOOD

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation
    2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
    4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
    6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
    8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
    9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
    10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
    11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/16/2009)... Dec. 16 According to Millennium Research ... market intelligence, although the US minimally invasive spinal ... growth rate of over 12% through 2014, reimbursement ... the overall market, which previously had been forecast ... for Minimally Invasive Spine Technologies 2010 ...
    (Date:12/16/2009)... Dec. 16 Ethicon, Inc., a Johnson ... and a worldwide leader in surgical care, and ... dedicated to designing, developing and commercializing devices that ... (ENT), today announced a definitive merger agreement whereby ... for approximately $785 million net of estimated cash ...
    (Date:12/16/2009)... at,deCODE genetics, Inc. (Nasdaq: DCGN ) publish in ... a common single-letter variant in the sequence of,the ... susceptibility to type 2,diabetes (T2D). The impact of ... unusual:,if an individual inherits it from their father, ... 30% compared to those who inherit the non ...
    Breaking Medicine Technology:Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 2Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 3Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination 50300 1Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination 50300 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 4665 1Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 4665 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 4665 3Peptic ulcer bacterium alters the bodys defense system 50296 1
    ... St. Jude Study Success in Using Virus Enzyme to ... Spray Could Be Used to,Prevent Both Ear Infection and ... 2007 /PRNewswire/ -- Parents might one,day give their children ... to prevent them from getting a severe middle ear,infection, ...
    ... Study Suggests the Drug Improves Memory, SARASOTA, Fla., ... today that it has received positive,preliminary results in ... new drug application for the treatment of Alzheimer's,disease. ... is the first human clinical study conducted by ...
    Other Medicine Technology:Viral Enzyme Recruited in Fight Against Ear Infection 2Viral Enzyme Recruited in Fight Against Ear Infection 3Sarasota's Roskamp Institute Announces Positive Safety Data in,Human Clinical Study for Alzheimer's Disease 2
    (Date:12/16/2009)... ANN ARBOR, Mich., Dec. 16 The most widely ... a finding that raises social justice questions that must ... benefit from stem cell advances, according to a University ... study of its kind, the U-M team analyzed 47 ... commonly used by stem cell researchers. The scientists determined ...
    (Date:12/16/2009)... HealthSciences Institute will sponsor a new learning ... organizations who serve individuals at risk of, ... health plan, medical home and other provider ... noncommercial webinars on topics, solutions and case ... care improvement. Each webinar will include a ...
    (Date:12/16/2009)... seven that increase susceptibility to disease , , WEDNESDAY, ... with increased susceptibility to leprosy have been identified ... researchers, who analyzed more than 10,000 DNA samples ... said their discovery highlights the important role that ... of leprosy. , "Though leprosy is not common, ...
    (Date:12/16/2009)... teams led by the Wellcome Trust Sanger Institute announce ... All cancers are caused by mutations in the DNA ... lifetime. The studies, of a malignant melanoma and a ... the mutations in the genomes of two cancers. , ... year: almost all are associated with smoking. The number ...
    (Date:12/16/2009)... University of Florida researchers at work on a ... to predict the spread of the disease using cell ... million calls to determine how often residents of Zanzibar ... of two islands off the coast of Tanzania in ... years. Its government commissioned the study as part of ...
    Breaking Medicine News(10 mins):Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Leprosy Genes Identified 2Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3
    ... the first time, have shown, using a new imaging ... the brain over time. Until now, MRI was used ... key area of the brain for memory and learning. ... larger brain areas. This is the first time a ...
    ... study published in the British Medical Journal, older people taking ... researchers from Cambridge, UK, identified a group of 2,686 people ... either one capsule of Vitamin D3 or a placebo every ... provide them with information on bone fractures// and any major ...
    ... and both in developed and developing countries heart disease ... - through premature death and disability. Researchers at the ... measures that could reduce the number of years lost ... could be divided// into non-personal and personal. Non-personal measures ...
    ... of Pittsburgh researchers are currently testing the safety ... traumatic brain injury. Hypothermia treatment has been shown ... in children, but its effectiveness in treating children ... studied. Hypothermia decreases inflammation, excitotoxicity (excessive neurotransmitters released ...
    ... now had only an option of a hysterectomy or removal ... fibroid with the drug Mifepristone. Lead researcher Steven H. Eisinger, ... in women and fibroid relief accounts for about 30% of ... have back pain, pain with intercourse, problems with bowels and ...
    ... stated that there is a metabolic threshold that occurs ... becomes deleterious for lumbar bone mineral density (LBMD) after ... 10-year period, investigated the longitudinal relationship between daily physical ... They assessed LMBD, habitual daily physical activity, total body ...
    Other Medicine News:Health News:Treatment for fibroids with "Abortion Pill" 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: